Differences in sedative susceptibility between types of depression. Clinical and neurophysiological significance.
D000328:Adult; D000367:Age Factors; D001008:Anxiety Disorders / Q000188:drug therapy*; D001143:Arousal / Q000187:drug effects; D001714:Bipolar Disorder / Q000188:drug therapy; D002490:Central Nervous System / Q000502:physiology; D003863:Depression / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy; D005260:Female; D005712:Galvanic Skin Response / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000494:pharmacology; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology; D008875:Middle Aged; D010919:Placebos; D011618:Psychotic Disorders / Q000188:drug therapy*; D012737:Sex Factors; D012890:Sleep / Q000187:drug effects*; D012964:Sodium; D013874:Thiopental / Q000627:therapeutic use
D007328:Insulin; D010919:Placebos; D008694:Methamphetamine; D012964:Sodium; D013874:Thiopental